Merit Medical Systems Stock Number Of Employees

MMSI Stock  USD 101.28  0.18  0.18%   
Merit Medical Systems fundamentals help investors to digest information that contributes to Merit Medical's financial success or failures. It also enables traders to predict the movement of Merit Stock. The fundamental analysis module provides a way to measure Merit Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Merit Medical stock.
Short Long Term Debt TotalTotal Assets
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Merit Medical Systems Company Number Of Employees Analysis

Merit Medical's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

Number of Employees

 = 

Full Time

+

Part Time

More About Number Of Employees | All Equity Analysis

Current Merit Medical Number Of Employees

    
  7.4 K  
Most of Merit Medical's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merit Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Merit Number Of Employees Driver Correlations

Understanding the fundamental principles of building solid financial models for Merit Medical is extremely important. It helps to project a fair market value of Merit Stock properly, considering its historical fundamentals such as Number Of Employees. Since Merit Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Merit Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Merit Medical's interrelated accounts and indicators.
0.990.820.960.980.980.950.410.930.960.950.880.980.920.60.850.730.50.640.8-0.930.010.890.720.81
0.990.780.960.990.930.920.50.920.970.980.80.980.920.620.870.770.450.650.8-0.940.020.850.660.85
0.820.780.850.770.830.750.060.840.720.70.830.830.750.30.660.570.520.420.54-0.63-0.10.710.510.7
0.960.960.850.940.920.940.290.840.930.880.870.930.860.460.790.810.360.480.68-0.85-0.010.860.730.87
0.980.990.770.940.930.890.540.930.970.980.790.980.950.640.870.710.530.70.8-0.960.020.830.620.81
0.980.930.830.920.930.950.280.910.90.890.950.940.870.550.80.660.540.610.77-0.87-0.010.90.770.72
0.950.920.750.940.890.950.20.790.880.850.930.870.770.560.810.830.260.460.72-0.85-0.020.940.880.83
0.410.50.060.290.540.280.20.450.530.63-0.010.510.580.50.470.140.460.650.47-0.630.10.15-0.080.28
0.930.920.840.840.930.910.790.450.870.920.780.940.890.630.750.540.670.790.86-0.850.130.770.510.66
0.960.970.720.930.970.90.880.530.870.950.760.960.930.540.820.70.480.60.77-0.920.010.810.630.8
0.950.980.70.880.980.890.850.630.920.950.710.960.920.720.880.70.490.740.85-0.970.030.810.580.8
0.880.80.830.870.790.950.93-0.010.780.760.710.810.710.390.660.640.40.410.62-0.7-0.010.880.840.66
0.980.980.830.930.980.940.870.510.940.960.960.810.950.570.840.660.60.680.77-0.930.00.810.590.79
0.920.920.750.860.950.870.770.580.890.930.920.710.950.470.810.530.660.660.69-0.9-0.090.690.470.68
0.60.620.30.460.640.550.560.50.630.540.720.390.570.470.670.560.210.680.75-0.740.210.610.440.54
0.850.870.660.790.870.80.810.470.750.820.880.660.840.810.670.780.280.490.64-0.9-0.390.80.610.86
0.730.770.570.810.710.660.830.140.540.70.70.640.660.530.560.78-0.180.180.51-0.71-0.150.790.740.95
0.50.450.520.360.530.540.260.460.670.480.490.40.60.660.210.28-0.180.70.46-0.470.160.19-0.030.03
0.640.650.420.480.70.610.460.650.790.60.740.410.680.660.680.490.180.70.83-0.70.340.470.220.31
0.80.80.540.680.80.770.720.470.860.770.850.620.770.690.750.640.510.460.83-0.790.310.790.570.57
-0.93-0.94-0.63-0.85-0.96-0.87-0.85-0.63-0.85-0.92-0.97-0.7-0.93-0.9-0.74-0.9-0.71-0.47-0.7-0.790.04-0.79-0.61-0.78
0.010.02-0.1-0.010.02-0.01-0.020.10.130.010.03-0.010.0-0.090.21-0.39-0.150.160.340.310.04-0.06-0.05-0.23
0.890.850.710.860.830.90.940.150.770.810.810.880.810.690.610.80.790.190.470.79-0.79-0.060.920.8
0.720.660.510.730.620.770.88-0.080.510.630.580.840.590.470.440.610.74-0.030.220.57-0.61-0.050.920.66
0.810.850.70.870.810.720.830.280.660.80.80.660.790.680.540.860.950.030.310.57-0.78-0.230.80.66
Click cells to compare fundamentals
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Competition

Based on the recorded statements, Merit Medical Systems is currently employing 7.4 K people. This is 32.71% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 7.41 K) industry. The number of employees for all United States stocks is 60.72% higher than that of the company.

Merit Number Of Employees Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Merit Medical's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Merit Medical could also be used in its relative valuation, which is a method of valuing Merit Medical by comparing valuation metrics of similar companies.
7.4K25.6K13.5K16.0K100%
Merit Medical is currently under evaluation in number of employees category among its peers.

Merit Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Merit Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Merit Medical's managers, analysts, and investors.
68.1%
Environmental
Governance
Social

Merit Fundamentals

Return On Equity0.0933
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-120%-100%-80%-60%-40%-20%
Return On Asset0.042
Profit Margin0.09 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-140%-120%-100%-80%-60%-40%-20%
Operating Margin0.11 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-140%-120%-100%-80%-60%-40%-20%
Current Valuation6.38 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%30,000%35,000%
Shares Outstanding58.83 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%300%
Shares Owned By Insiders2.57 %
Shares Owned By Institutions97.43 %
Number Of Shares Shorted3.01 M
Price To Earning956.67 X
Price To Book4.33 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Price To Sales4.39 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Revenue1.36 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3120,000%40,000%60,000%80,000%100,000%
Gross Profit643.33 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-200,000%-150,000%-100,000%-50,000%
EBITDA295.94 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100,000%-80,000%-60,000%-40,000%-20,000%
Net Income120.36 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-30,000%-25,000%-20,000%-15,000%-10,000%-5,000%0%
Cash And Equivalents51.48 M
Cash Per Share0.91 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%
Total Debt810.12 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100,000%200,000%300,000%400,000%
Debt To Equity0.26 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-50%0%50%100%150%200%250%
Current Ratio2.35 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150%100%150%200%250%
Book Value Per Share23.48 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%30,000%35,000%
Cash Flow From Operations220.8 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110,000%20,000%30,000%40,000%50,000%60,000%70,000%
Short Ratio5.31 X
Earnings Per Share2.03 X
Price To Earnings To Growth2.41 X
Target Price118.2
Number Of Employees7.4 K
Beta0.92
Market Capitalization5.96 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315,000%10,000%15,000%20,000%25,000%30,000%35,000%
Total Asset2.42 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3150,000%100,000%150,000%
Retained Earnings695.54 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100,000%-80,000%-60,000%-40,000%-20,000%
Working Capital707.37 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset204 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3120,000%40,000%60,000%80,000%100,000%120,000%140,000%
Current Liabilities87.91 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3110,000%20,000%30,000%40,000%
Net Asset2.42 B

About Merit Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Merit Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merit Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merit Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.04)
Earnings Share
2.03
Revenue Per Share
23.301
Quarterly Revenue Growth
0.094
Return On Assets
0.042
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.


 
News Freq…Investor S…